No Survival Benefit with Empirical Vancomycin Therapy for Coagulase-negative Staphylococcal Bloodstream Infections in Infants

BACKGROUND: Coagulase-negative Staphylococcus (CoNS) is the most common cause of bloodstream infections (BSI) in hospitalized infants. CoNS BSI is most reliably treated with vancomycin; however, concerns about side effects and promoting resistance often delay empirical vancomycin therapy until cultu...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Pediatr Infect Dis J
Huvudupphovsmän: Ericson, Jessica E., Thaden, Joshua, Cross, Heather R., Clark, Reese H., Fowler, Vance G., Benjamin, Daniel K., Cohen-Wolkowiez, Michael, Hornik, Christoph P., Smith, P. Brian
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2015
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4357312/
https://ncbi.nlm.nih.gov/pubmed/25760564
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/INF.0000000000000573
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk